Carotid body tumor surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 45: Line 45:
*Individuals with concurrent jugular or vagal paragangliomas and no evidence of lower cranial nerve dysfunction
*Individuals with concurrent jugular or vagal paragangliomas and no evidence of lower cranial nerve dysfunction
*Individuals with multiple or bilateral tumors with the potential for severe postoperative debility from cranial nerve dysfunction
*Individuals with multiple or bilateral tumors with the potential for severe postoperative debility from cranial nerve dysfunction
==Observation==
Another policy in approaching carotid body tumor is observation. There is limited data regarding this policy, however, some studies recommended this policy considering the benign nature of the tumor and its slow growth nature.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 20:33, 10 April 2019

Carotid body tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carotid Body Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carotid body tumor surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carotid body tumor surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carotid body tumor surgery

CDC on Carotid body tumor surgery

Carotid body tumor surgery in the news

Blogs on Carotid body tumor surgery

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Carotid body tumor surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Traditionally, surgery is considered the mainstay of treatment for the carotid body tumor. However, there is a growing amount of studies observing that radiotherapy can be used as an alternative treatment with equal efficacy and lower complications.

Surgery

Surgery is the treatment of choice for carotid body tumor.[1]

  • Surgical approach of the tumor is different for each Shamblin subclassification:
    • For Shamblin type I/II case without an abundant blood supply, simple resection of the tumor is the optimal treatment.
    • For Shamblin type III cases with large tumors and malignant tumors involving important peripheral vessels resection and reconstructive vascular operation (including simple vascular anastomosis, internal carotid artery-common carotid artery artificial and autologous reconstructive vascular operation) is appropriate.

Indications

Surgery is indicated in:[2]

  • Individuals with small to moderate-sized carotid body tumors and tympanic paragangliomas without cranial nerve dysfunction
  • Younger and middle-aged patients without coexisting medical problems
  • Individuals with a malignant tumor
    • Postoperative radiation therapy is also should be considered.

Contraindications

Individuals who are poor candidates of surgery due to any reason.[3]

Complications of surgery

Surgical excision of the tumor may be complicated by:

  • Cranial nerve involvement in 10% to 56% of the cases.
  • The most commonly involved nerves are such as:
    • The hypoglossal nerve
    • The superior laryngeal nerve
    • The vagus nerve,
    • The mandibular branch of the facial nerve
    • The pharyngeal branch of the vagus nerve
    • The glossopharyngeal nerve
    • The spinal accessory nerve
    • The sympathetic chain

Radiotherapy

  • Although previous literature claimed that radiotherapy is not effective for the treatment of the tumor, current studies have shown that the efficacy is comparable to those of the surgery.[1][2][4]
  • Also, studies have shown that the complications of radiotherapy are lower in comparison with surgery.

Indications for radiotherapy

Radiotherapy is indicated in:[2]

  • Elderly individuals
  • High-risk patients with multiple or severe medical conditions
  • Individuals with extensive skull-base or intracranial involvement
  • Individuals with concurrent jugular or vagal paragangliomas and no evidence of lower cranial nerve dysfunction
  • Individuals with multiple or bilateral tumors with the potential for severe postoperative debility from cranial nerve dysfunction

Observation

Another policy in approaching carotid body tumor is observation. There is limited data regarding this policy, however, some studies recommended this policy considering the benign nature of the tumor and its slow growth nature.

References

  1. 1.0 1.1 Luo T, Zhang C, Ning YC, Gu YQ, Li JX, Wang ZG (March 2013). "Surgical treatment of carotid body tumor: case report and literature review". J Geriatr Cardiol. 10 (1): 116–8. doi:10.3969/j.issn.1671-5411.2013.01.018. PMC 3627704. PMID 23610583.
  2. 2.0 2.1 2.2 Hu K, Persky MS (July 2003). "Multidisciplinary management of paragangliomas of the head and neck, Part 1". Oncology (Williston Park, N.Y.). 17 (7): 983–93. PMID 12886866.
  3. Eisele, David (2008). Complications in head and neck surgery. Edinburgh: Saunders. ISBN 978-1-4160-4220-4.
  4. Suárez, Carlos; Rodrigo, Juan P.; Mendenhall, William M.; Hamoir, Marc; Silver, Carl E.; Grégoire, Vincent; Strojan, Primož; Neumann, Hartmut P. H.; Obholzer, Rupert; Offergeld, Christian; Langendijk, Johannes A.; Rinaldo, Alessandra; Ferlito, Alfio (2013). "Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy". European Archives of Oto-Rhino-Laryngology. 271 (1): 23–34. doi:10.1007/s00405-013-2384-5. ISSN 0937-4477.